Literature DB >> 21170889

Low urinary citrate: an overview.

Miriam Zacchia1, Patricia Preisig.   

Abstract

Hypocitraturia is a known risk factor for kidney stone formation. By forming soluble complexes with calcium, citrate prevents crystal nucleation, aggregation and growth; therefore, the presence of citrate in the urine reduces the risk for calcium stone formation. Ingested citrate is rapidly metabolized, and plasma citrate levels vary little, so changes in filtered load do not significantly influence urinary citrate excretion. Changes in urinary citrate excretion are predominantly influenced by the rate of citrate absorption from the glomerular filtrate and metabolism by the proximal tubule cell. The former is mediated by the apical membrane cotransporter NaDC1, and the latter is mediated by both cytoplasmic and mitochondrial metabolism. Acid-base status is the most important physiological determinant of urinary citrate excretion, by modulating the activities of NaDC1 and cytoplasmic (ATP citrate lyase) and mitochondrial (m-aconitase) enzymes involved in citrate metabolism. Following an acid load, both the transport and metabolic processes are up-regulated leading to hypocitraturia; in contrast, an alkaline load increases citrate excretion, by regulating only the mitochondrial metabolic process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21170889

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  16 in total

1.  Evidence for epistatic interaction between VDR and SLC13A2 genes in the pathogenesis of hypocitraturia in recurrent calcium oxalate stone formers.

Authors:  Domenico Rendina; Gianpaolo De Filippo; Fernando Gianfrancesco; Riccardo Muscariello; Michele Schiano di Cola; Pasquale Strazzullo; Teresa Esposito
Journal:  J Nephrol       Date:  2016-09-17       Impact factor: 3.902

Review 2.  Ammonia Transporters and Their Role in Acid-Base Balance.

Authors:  I David Weiner; Jill W Verlander
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

3.  Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion.

Authors:  Ernest I Mandel; Eric N Taylor; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

4.  Acid Stimulation of the Citrate Transporter NaDC-1 Requires Pyk2 and ERK1/2 Signaling Pathways.

Authors:  Miriam Zacchia; Xuefei Tian; Enrica Zona; Robert J Alpern; Patricia A Preisig
Journal:  J Am Soc Nephrol       Date:  2018-04-20       Impact factor: 10.121

5.  Plasma Citrate Homeostasis: How It Is Regulated; And Its Physiological and Clinical Implications. An Important, But Neglected, Relationship in Medicine.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  HSOA J Hum Endocrinol       Date:  2016-12-31

6.  SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis.

Authors:  Ehud Ohana; Nikolay Shcheynikov; Orson W Moe; Shmuel Muallem
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

7.  Mechanism for higher urine pH in normal women compared with men.

Authors:  Elaine M Worcester; Kristin J Bergsland; Daniel L Gillen; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2017-12-20

8.  Prospective relation of adolescent citrate excretion and net acid excretion capacity with blood pressure in young adulthood.

Authors:  Danika Krupp; Timm H Westhoff; Jonas Esche; Thomas Remer
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-18

9.  Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease.

Authors:  Martin Gritter; Liffert Vogt; Stanley M H Yeung; Rosa D Wouda; Christian R B Ramakers; Martin H de Borst; Joris I Rotmans; Ewout J Hoorn
Journal:  Nephron       Date:  2018-06-29       Impact factor: 2.847

10.  Cortisol and 11 beta-hydroxysteroid dehydrogenase type 2 as potential determinants of renal citrate excretion in healthy children.

Authors:  Yifan Hua; Jonas Esche; Michaela F Hartmann; Christiane Maser-Gluth; Stefan A Wudy; Thomas Remer
Journal:  Endocrine       Date:  2019-12-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.